Patent · US Active

Safe sequencing system

US11180803B2 · kind B2 · utility

3Cited by
151References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 18, 2016
Grant dateNov 23, 2021
Priority date
Expiry dateAug 18, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Though massively parallel sequencing instruments are in principle well-suited to the task of identification of mutations present in a small fraction of DNA templates, the error rates in such instruments are generally too high to allow confident identification of rare variants. An approach that can substantially increase the sensitivity of massively parallel sequencing instruments for this purpose is called “Safe-SeqS” for (Safe-Sequencing System) and includes (i) assignment of a unique identifier (UID) to each template molecule; (ii) amplification of each uniquely tagged template molecule to create UID-families; and (iii) redundant sequencing of the amplification products. PCR fragments with the same UID are truly mutant (“super-mutants”) if ≥95% of them contain the identical mutation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.